Health

I-Mab Announces Upcoming Participation at March Conferences

SHANGHAI and GAITHERSBURG, Md., Feb. 24, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in March....

2021-02-24 21:00 4773

Occlutech announces Completion of Patient Enrolment in Pilot Study of Atrial Flow Regulator (AFR) in Patients with Heart Failure

SCHAFFHAUSEN, Switzerland, Feb. 24, 2021 /PRNewswire/ -- Occlutech, a privately-held company, announced today the completion of patient enrolment in its pilot study to assess safety and efficacy of the novel Atrial Flow Regulator (AFR) in heart failure (HF) patients (PRELIEVE trial). PRELIEVE is...

2021-02-24 20:41 2343

MedTech to Take Advantage of Digital Health Platform as a Service Model to Accelerate Digital Transformation across the Healthcare Industry

A proven, compliant platform can expedite market entry and optimize time and effort without building competencies internally, finds Frost & Sullivan SANTA CLARA, Calif., Feb. 24, 2021 /PRNewswire/ -- MedTech and Life Sciences companies are transitioning beyondbiopharmaceuticals, medical devices, ...

2021-02-24 20:02 1867

Advanced Aesthetic Technologies, Inc.'s Algeness® Chosen as a Top Finalist in Prestigious Terra2 Solution Skin Health Innovation Competition

BROOKLINE, Mass., Feb. 24, 2021 /PRNewswire/ -- Advanced Aesthetic Technologies, Inc. (AAT), a leader in aesthetic gel implant technology, is proud to announce that AAT and our lead product Algeness® were selected as one of the top two finalists in the recent Terra2 Solutions Skin Health Innovati...

2021-02-24 19:00 2864

Mohamed bin Zayed University of Artificial Intelligence and Weizmann Institute of Science establish joint AI Program

- New collaborative projects will facilitate joint research projects, training programs, conferences, student exchange programs and more ABU DHABI, UAE, Feb. 24, 2021 /PRNewswire/ -- The Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) and the Weizmann Institute of Science (WIS) ...

2021-02-24 16:28 3332

INOVIO and QIAGEN expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO's VGX-3100 for advanced cervical dysplasia

- Liquid biopsy-based precision test guides patient selection and offers potential for cost-effective, non-invasive alternative to surgical removal of cervical lesions - QIAGEN's bioinformatic expertise raises predictive biomarker power in INOVIO's patient selection - First-in-class next genera...

2021-02-24 14:45 6145

Additional Positive Interim Results from Nanoform's Clinical Study

HELSINKI, Feb. 24, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, today announced further positive interim results from its ongoing clinical study. The fast absorption data implies that small is powerful® and might offer viable alternatives to com...

2021-02-24 14:33 1299

Alternative meat startup Next Meats Co., Ltd and microalgae biotech company euglena Co., launch "NEXT Euglena Yakiniku EX" containing microalgae

TOKYO, Feb. 12, 2021 /PRNewswire/ -- Next Meats Co., LTD, the controlling shareholder of Next Meats Holdings, Inc. ("OTC: NXMH") announced that they had signed a joint product development agreement witheuglena Co., a biotech company also fromJapan which specializes in cultivating Euglena and Chlo...

2021-02-24 12:45 5637

Antengene Announces NDA for ATG-010 (Selinexor) Granted Priority Review by China's NMPA

SHANGHAI and HONG KONG, Feb. 24, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and onco...

2021-02-24 08:00 3042

WuXi Diagnostics Secures US$150 Million Series B Financing to Accelerate Market Penetration in Global Diagnostics Sector

SHANGHAI, Feb. 23, 2021 /PRNewswire/ -- WuXi Diagnostic Investment (Cayman) Limited ("WuXi Diagnostics") announced that it has completedUS$150 million in series B funding, joined by new investors including Thermo Fisher Scientific Inc. ("Thermo Fisher"), Shiyu Capital ("SHIYU"), ABC International...

2021-02-24 08:00 2331

Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc.

TOKYO, Feb. 23, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543), a global leader in medical technology, has signed a definitive agreement to acquire all assets of Health Outcomes Sciences, Inc. (HOS). HOS specializes in predictive analytics and clinical decision support that enable healthcare...

2021-02-24 07:00 8502

US Court Grants MGI's Motion to Amend in Suit Against Illumina

SAN FRANCISCO, Feb. 24, 2021 /PRNewswire/ -- A judge in the U.S. District Court for the Northern District ofCalifornia has granted MGI's motion for leave to amend to add a new inequitable conduct defense of patent infringement lawsuit that Illumina filed against MGI inFebruary 2020 (Case No. 20-c...

2021-02-24 04:00 3654

New Research Highlights the Potential of Transforming Healthcare with Mobile EEG Brain Health Assessments

Recent publications in Frontiers of Neuroscience, Scientific Report and Neurophysiologie Clinique validate the use of Muse® as a mobile EEG device to measure brain health and performance at scale in real-world environments TORONTO, Feb. 24, 2021 /PRNewswire/ -- In a time with overburdened healthc...

2021-02-24 03:21 1570

GBB Completes USD$3.8M Convertible Note Financing Led by Alibaba Hong Kong Entrepreneurs Fund

HONG KONG, Feb. 23, 2021 /PRNewswire/ -- Great Bay Bio Holdings Limited (hereinafter referred to as "GBB") today announced it has completed aUSD$3.8M Convertible Note Financing. Alibaba Hong Kong Entrepreneurs Fund (hereinafter referred to as "AEF") led the investment round with participation fro...

2021-02-23 23:00 2076

Skybox Security Announces 2020 Partner Awards

Channel and distributor partners recognized for commitment to customer excellence and performance SAN JOSE, Calif., Feb. 23, 2021 /PRNewswire/ -- Skybox Security, a global leader in security posture management, today announced the winners of its 2020 Partner Awards. The inaugural award program r...

2021-02-23 22:05 2229

Rheumatology Clinical Researcher Professor David Hunter Joins George Clinical Scientific Leadership

OVERLAND PARK, Kan., Feb. 23, 2021 /PRNewswire/ -- David Hunter, MBBS, PhD, a renowned clinical researcher and rheumatology expert based inAustralia, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization. Professor Hunter's researc...

2021-02-23 22:00 1358

ScImage Lauded by Frost & Sullivan for Its Cloud-based Enterprise Imaging Platform, PICOM365

Its seamless integration across imaging programs and tools give physicians single-platform access to all the tools needed to view and interpret images and videos from anywhere SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Based on its recent analysis of the North American cloud-based enterp...

2021-02-23 22:00 1609

Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021

SUZHOU and SHANGHAI, China, Feb. 23, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies, today announced that it plans to release ...

2021-02-23 21:00 7880

INOVIO Announces First Subject Dosed in Phase 1B Clinical Trial for its DNA Vaccine Against Lassa Fever, INO-4500, in West Africa

Phase 1B clinical trial is first study for Lassa fever conducted in Africa Goal is for vaccine to be available for emergency use as stockpile product following Phase 2 Progress on INO-4500 reflects INOVIO's focus on and continued commitment to the fight against infectious diseases Trial fully f...

2021-02-23 21:00 4942

Inovalon Lauded by Frost & Sullivan for Continuously Advancing Data-Driven Healthcare with Its Cloud-Based Inovalon ONE® Platform

Inovalon combines industry interconnectivity, large-scale, comprehensive data assets, and analytics with subject matter expertise to support clients strategically SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Based on its recent analysis of the North American healthcare and life sciences an...

2021-02-23 21:00 4910
1 ... 652653654655656657658 ... 858